Science & Enterprise subscription

Follow us on Twitter

  • The Pew Research Center last month reported results of surveys about mobile phone use, conducted in 11 emerging eco… https://t.co/EEmV2FmKas
    about 13 hours ago
  • New post on Science and Enterprise: Infographic – Mobile Phones in Emerging Economies https://t.co/MXoyQkhwIu #Science #Business
    about 14 hours ago
  • Thank you @SciSeeker ... that's very kind. Where can I find a Science Seeker logo I can put on our site, to indicat… https://t.co/kXVMa32BHZ
    about 1 day ago
  • A biomedical engineering team devised techniques using a gel to produce more engineered T-cells, which in lab mice… https://t.co/d9GwEsAjxo
    about 2 days ago
  • New post on Science and Enterprise: Gel Boosts T-Cells for Cancer Treatments https://t.co/3SJaw4iYkL #Science #Business
    about 2 days ago

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn
INSTAGRAM

Gel Boosts T-Cells for Cancer Treatments

T-cells illustration

A biomedical engineering team devised techniques using a gel to produce more engineered T-cells, which in lab mice stopped the growth of tumors. . . . → Read More: Gel Boosts T-Cells for Cancer Treatments

Patent Awarded for Engineered T-Cell Cancer Therapy

Human T-cell

An experimental treatment using a person’s modified T-cells from the immune system to attack solid tumor cancers received a U.S. patent. . . . → Read More: Patent Awarded for Engineered T-Cell Cancer Therapy

Human Heart 3-D Printed from Patient Cells

3-D printed heart

A biomedical engineering team printed a three-dimensional scale model of a human heart, including blood vessels, from cells donated by a living person. . . . → Read More: Human Heart 3-D Printed from Patient Cells

Resistant Fungus Treatment Shown Effective in Early Results

Petri dishes

Results from a clinical trial show an experimental anti-fungal drug effective in 2 cases of Candida auris infections, a fungus resistant to most other drugs. . . . → Read More: Resistant Fungus Treatment Shown Effective in Early Results

FDA Approves Single Dual-Drug Pill for HIV

HIV released from cell

The Food and Drug Administration approved a daily pill with 2 drugs to lower viral loads in people with HIV, but who have not yet taken other HIV drugs. . . . → Read More: FDA Approves Single Dual-Drug Pill for HIV

Biotechs Partner on Gene Silencing in $1.1B Deal

Retinal gene therapy

Two biotechnology companies plan to develop new therapies mainly for eye and neurological diseases that silence genes responsible for those conditions. . . . → Read More: Biotechs Partner on Gene Silencing in $1.1B Deal

NIH Launches Universal Flu Vaccine Trial

3-D print of influenza virus

A clinical trial testing a vaccine designed to prevent infections from many influenza strains is underway at National Institutes of Health. . . . → Read More: NIH Launches Universal Flu Vaccine Trial

Biotechs Join Forces for Off-the-Shelf Stem Cells

Crispr genome edits illustration

Two biotechnology enterprises working in genome editing and regenerative medicine are sharing their technologies to develop off-the-shelf cell therapies. . . . → Read More: Biotechs Join Forces for Off-the-Shelf Stem Cells

Radiation-Antibody Biotech Raises $105M in Venture Funds

John Valiant

A company creating cancer treatments that combine radiation therapy with the targeting of synthetic antibodies is raising $105 million in its second round of venture financing. . . . → Read More: Radiation-Antibody Biotech Raises $105M in Venture Funds

Trial Underway Testing Nasal Spray Migraine Therapy

Man with depression

A clinical trial is recruiting participants to test a treatment for migraine that delivers the drug as a nasal spray. . . . → Read More: Trial Underway Testing Nasal Spray Migraine Therapy